We have also discussed potential biomarkers involved in pathways that are differentially affected or modified during the onset of HPV-related cancers, such as Akt, mTOR, miRNAs, TNF-α, TGF-β, BRCA1, and FANCD2. This evidence concerns the gene FANCD2 and cancer.